Edition:
United States

Perrigo Company PLC (PRGO.N)

PRGO.N on New York Stock Exchange

88.25USD
23 Feb 2018
Change (% chg)

$1.18 (+1.36%)
Prev Close
$87.07
Open
$87.50
Day's High
$88.38
Day's Low
$87.17
Volume
164,752
Avg. Vol
298,934
52-wk High
$95.82
52-wk Low
$63.69

Chart for

About

Perrigo Company PLC (Perrigo), formerly Perrigo Company Limited, is an over-the-counter (OTC) consumer goods and specialty pharmaceutical company. The Company's segments include Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals (Rx) and Specialty Sciences. It manufactures OTC healthcare... (more)

Overall

Beta: 0.76
Market Cap(Mil.): $12,429.19
Shares Outstanding(Mil.): 140.84
Dividend: 0.19
Yield (%): 0.86

Financials

  Industry Sector
P/E (TTM): -- 30.98 16.31
EPS (TTM): -- -- --
ROI: -- 14.12 35.74
ROE: -- 15.72 17.71

BRIEF-Perrigo Confirms Patent Challenge For Generic Version Of Finacea Foam, 15%

* PERRIGO CONFIRMS PATENT CHALLENGE FOR GENERIC VERSION OF FINACEA® FOAM, 15%

Feb 20 2018

BRIEF-Perrigo Appoints Ronald Winowiecki As CFO

* PERRIGO APPOINTS RONALD L. WINOWIECKI AS CHIEF FINANCIAL OFFICER

Feb 20 2018

BRIEF-Perrigo Announces Tentative FDA Approval For The Generic Version Of Soolantra Cream, 1%

* PERRIGO ANNOUNCES TENTATIVE FDA APPROVAL FOR THE GENERIC VERSION OF SOOLANTRA® CREAM, 1% Source text for Eikon: Further company coverage:

Jan 30 2018

BRIEF-Perrigo Announces Final FDA Approval Of A Generic Version Of Estrace Cream

* PERRIGO ANNOUNCES FINAL FDA APPROVAL OF A GENERIC VERSION OF ESTRACE CREAM

Jan 24 2018

BRIEF-Perrigo Announces Final FDA Approval And Launch Of An AB Rated Generic Version Of Epiduo Gel

* PERRIGO ANNOUNCES FINAL FDA APPROVAL AND LAUNCH OF AN AB RATED GENERIC VERSION OF EPIDUO GEL Source text for Eikon: Further company coverage:

Jan 24 2018

BRIEF-Perrigo Says In Connection With Uwe Röhrhoff's Appointment As CEO, Co's Unit Perrigo DAC Entered Into Employment Agreement With Him

* PERRIGO COMPANY - IN CONNECTION WITH UWE RÖHRHOFF'S APPOINTMENT AS CEO, CO'S UNIT PERRIGO DAC ENTERED INTO AN EMPLOYMENT AGREEMENT WITH HIM

Jan 08 2018

Perrigo hires Gerresheimer ex-boss Rohrhoff as new CEO

Generic drugmaker Perrigo Company Plc appointed Uwe Rohrhoff, former CEO of Gerresheimer AG, as its new chief executive, the company said on Monday.

Jan 08 2018

UPDATE 1-Perrigo hires Gerresheimer ex-boss Rohrhoff as new CEO

Jan 8 Generic drugmaker Perrigo Company Plc appointed Uwe Rohrhoff, former CEO of Gerresheimer AG , as its new chief executive, the company said on Monday.

Jan 08 2018

Perrigo hires Gerresheimer ex-boss Rohrhoff as new CEO

Jan 8 Generic drugmaker Perrigo Company Plc appointed former Gerresheimer AG Chief Executive Uwe Rohrhoff as its new president and CEO, the company said on Monday.

Jan 08 2018

BRIEF-Perrigo appoints Uwe Röhrhoff as CEO

* PERRIGO APPOINTS UWE RÖHRHOFF AS PRESIDENT & CHIEF EXECUTIVE OFFICER

Jan 08 2018

Earnings vs. Estimates